Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer

Background: Breast cancer is the most common cancer among women. Genetic is a proven risk factor in this disease. As breast cancer genes (BRCA1 and BRCA2) affect the incidence of this type of cancer, identification of mutation carriers is important in reduction of the overall risk. The purpose of th...

Full description

Bibliographic Details
Main Authors: Mohammad Hassan Tajadini, Houra Khadem, Meraj Pourhosein, Ali Mohammad Sabzghabaee, Simin Hemati, Hamid Mirmohammad Sadeghi
Format: Article
Language:fas
Published: Vesnu Publications 2013-02-01
Series:مجله دانشکده پزشکی اصفهان
Online Access:http://jims.mui.ac.ir/index.php/jims/article/view/2217
id doaj-e121de6be33b46be99c5df6917b83df3
record_format Article
spelling doaj-e121de6be33b46be99c5df6917b83df32020-11-25T00:44:04ZfasVesnu Publications مجله دانشکده پزشکی اصفهان1027-75951735-854X2013-02-0130218221722241232Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast CancerMohammad Hassan Tajadini0Houra Khadem1Meraj Pourhosein2Ali Mohammad Sabzghabaee3Simin Hemati4Hamid Mirmohammad Sadeghi5MSc Student, Physiology Research Center AND Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, IranStudent of Pharmacy, School of Pharmacy and Pharmaceutical Sciences AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, IranAssociate Professor, Department of Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranAssociate Professor, Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, IranAssistant Professor, Department of Radiotherapy and Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranProfessor, Department of Biotechnology, School of Pharmacy and Pharmaceutical Sciences AND Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, IranBackground: Breast cancer is the most common cancer among women. Genetic is a proven risk factor in this disease. As breast cancer genes (BRCA1 and BRCA2) affect the incidence of this type of cancer, identification of mutation carriers is important in reduction of the overall risk. The purpose of this study was to determine the prevalence of BRCA1 and BRCA2 mutations in patients with breast cancer using high resolution melting (HRM) analysis. Methods: Blood samples of 41 female patients with breast cancer and 20 healthy women were collected randomly. The studied mutations were 185delAG, 5382insC, 3889delAG and 1476delG in BRCA1 and 6174delT and 6033-34insGT in BRCA2. Genomic DNA was extracted from blood samples. Forward and reverse primers were designed for each mutation. DNA samples of healthy individuals were sequenced to make sure about the absence of the studied mutations. Real-time polymerase chain reaction (PCR) and HRM analysis were performed and HRM and melting curves were plotted for all samples. For each mutation, some random samples were sequenced. The curves in the case and control groups were compared for each mutation. Findings: The desired mutations were not observed in any samples of the case group. Sequenced samples confirmed the HRM results. Conclusion: Due to the low number of samples and lack of known native mutations, observation and identification of mutations seem to be impossible in studies such as the present one. However, this study can serve as a base for extensive and applied studies of native and non-native mutations in Iranian population. Keywords: Breast cancer, BRCA1 gene, BRCA2 gene, High resolution meltinghttp://jims.mui.ac.ir/index.php/jims/article/view/2217
collection DOAJ
language fas
format Article
sources DOAJ
author Mohammad Hassan Tajadini
Houra Khadem
Meraj Pourhosein
Ali Mohammad Sabzghabaee
Simin Hemati
Hamid Mirmohammad Sadeghi
spellingShingle Mohammad Hassan Tajadini
Houra Khadem
Meraj Pourhosein
Ali Mohammad Sabzghabaee
Simin Hemati
Hamid Mirmohammad Sadeghi
Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer
مجله دانشکده پزشکی اصفهان
author_facet Mohammad Hassan Tajadini
Houra Khadem
Meraj Pourhosein
Ali Mohammad Sabzghabaee
Simin Hemati
Hamid Mirmohammad Sadeghi
author_sort Mohammad Hassan Tajadini
title Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer
title_short Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer
title_full Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer
title_fullStr Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer
title_full_unstemmed Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer
title_sort investigating the prevalence of brca1 and brca2 gene mutations in patients with breast cancer
publisher Vesnu Publications
series مجله دانشکده پزشکی اصفهان
issn 1027-7595
1735-854X
publishDate 2013-02-01
description Background: Breast cancer is the most common cancer among women. Genetic is a proven risk factor in this disease. As breast cancer genes (BRCA1 and BRCA2) affect the incidence of this type of cancer, identification of mutation carriers is important in reduction of the overall risk. The purpose of this study was to determine the prevalence of BRCA1 and BRCA2 mutations in patients with breast cancer using high resolution melting (HRM) analysis. Methods: Blood samples of 41 female patients with breast cancer and 20 healthy women were collected randomly. The studied mutations were 185delAG, 5382insC, 3889delAG and 1476delG in BRCA1 and 6174delT and 6033-34insGT in BRCA2. Genomic DNA was extracted from blood samples. Forward and reverse primers were designed for each mutation. DNA samples of healthy individuals were sequenced to make sure about the absence of the studied mutations. Real-time polymerase chain reaction (PCR) and HRM analysis were performed and HRM and melting curves were plotted for all samples. For each mutation, some random samples were sequenced. The curves in the case and control groups were compared for each mutation. Findings: The desired mutations were not observed in any samples of the case group. Sequenced samples confirmed the HRM results. Conclusion: Due to the low number of samples and lack of known native mutations, observation and identification of mutations seem to be impossible in studies such as the present one. However, this study can serve as a base for extensive and applied studies of native and non-native mutations in Iranian population. Keywords: Breast cancer, BRCA1 gene, BRCA2 gene, High resolution melting
url http://jims.mui.ac.ir/index.php/jims/article/view/2217
work_keys_str_mv AT mohammadhassantajadini investigatingtheprevalenceofbrca1andbrca2genemutationsinpatientswithbreastcancer
AT hourakhadem investigatingtheprevalenceofbrca1andbrca2genemutationsinpatientswithbreastcancer
AT merajpourhosein investigatingtheprevalenceofbrca1andbrca2genemutationsinpatientswithbreastcancer
AT alimohammadsabzghabaee investigatingtheprevalenceofbrca1andbrca2genemutationsinpatientswithbreastcancer
AT siminhemati investigatingtheprevalenceofbrca1andbrca2genemutationsinpatientswithbreastcancer
AT hamidmirmohammadsadeghi investigatingtheprevalenceofbrca1andbrca2genemutationsinpatientswithbreastcancer
_version_ 1725276864091521024